Carl Zeiss Meditec Stock – Fundamental Analysis

Price
33.02
10/14/2026
Mar 2000
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 12/14/2025)

Balance Sheet Total Assets 3,459,437,000.00 ROE 62.19 %
Balance Sheet Total Equity 2,116,510,000.00 ROA 4.15 %
Cashflow Capital Expenditures -76,593,000.00 P/FCF 21.69
Cashflow Free Cash Flow 133,265,000.00 – –
Cashflow Operating Cash Flow 209,858,000.00 P/CF 13.77
Income Earnings per Share (diluted) 1.61 Div. Yield 1.82 %
Income Net Income 141,210,000.00 P/E 20.51
Income Shares Outstanding 87,536,079.00 P/B 1.37
Income Total Revenue 2,227,645,000.00 P/S 1.30

Ratios calculated on: 10/14/2026

Company Description

Carl Zeiss Meditec AG is a Germany-based medical technology solutions supplier, specializing in Ophthalmology and Neuro/Ear Nose Throat surgery. Its diagnostic and therapeutic solutions are used for treating four main ophthalmic conditions: vision defects, cataracts, glaucoma and retinal disorders. The Company's solutions include optical biometry equipment; optical coherence tomography equipment; lens analyzers; fundus imaging cameras; standard and refractive ophthalmic lasers and slit lamps. In the field of Neurosurgery, it offers visualization solutions and surgical microscopes, used in clinical treatment of accidents, nerve reconstruction and pediatric neurosurgery. It is also involved in the development of visualization solutions in the area of intraoperative radiation therapy. The Company has subsidiaries in Germany, France, Spain, the United States, Japan, Mauritius and the United Kingdom, as well as distribution companies and agencies globally

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.meditec.zeiss.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more